Patient access to care and medication adherence have been ongoing challenges in the healthcare industry, especially during the COVID-19 pandemic. But pharmacists can play a valuable role in connecting...
FDA recently granted Daiichi Sankyo’s Enhertu breakthrough therapy designation in the US to treat adult patients with unresectable or metastatic HER2-positive breast cancer.
Enhertu is an...
Thermo Fisher Scientific recently launched a new mass spectrometry (MS) portfolio to advance quantitative analysis.
The Thermo Scientific TSQ Plus triple quadrupole MS portfolio increases...
Black Americans are still significantly underrepresented in cardiovascular disease clinical trials, and enrollment rates have not improved over time, according to a new paper published in the Journal...
The US pharmaceutical supply chain must be remodeled to address long-standing conflicts and achieve a delivery model marked by transparency, affordability, and access to care, according to an expert...
Abbott and Walgreens recently launched a pilot program to increase access to rapid COVID-19 testing for Pennsylvania Electronic Benefit Transfer (EBT) cardholders in the city of Philadelphia.
Under...
Moderna recently announced a supply agreement with the government of Australia for 25 million doses of its mRNA COVID-19 vaccine and booster variant candidate.
Ten million doses of...
Digital therapeutics company, MedRhythms, recently announced the launch of a clinical trial to study the company’s digital therapeutics trial for stroke, MR-010.
In partnership with UMass...
CVS Health recently announced that it began administering COVID-19 vaccines at workplace vaccination sites to increase access to vaccinations.
The vaccination increase comes on the heels of...
The Federal Trade Commission (FTC) recently filed an administrative complaint and authorized a federal court lawsuit to block Illumina’s $7.1 million pharma acquisition deal of cancer detection...
The Biden Administration recently released new prescription drug policy priorities that focus on addressing the opioid epidemic and reducing drug overdoses.
The priorities provide guideposts to...
FDA recently granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1) COVID-19 diagnostic test.
BioFire RP2.1 is used for the simultaneous qualitative detection of multiple...
Eli Lilly & Company recently announced new data showing that its combination COVID-19 antibody therapy significantly reduced COVID-19 hospitalizations and deaths in high-risk coronavirus...
In an official letter to President Joe Biden, PhRMA and over 30 leaders in the biopharmaceutical warned that eliminating intellectual property (IP) protections in COVID-19 vaccine development could...
Racial and ethnic diversity in clinical trials is lacking despite FDA recommendations regarding demographic characteristics of specific study populations, according to a recent JAMA Network Open...
FDA recently issued three guidance documents for COVID-19 vaccine developers and other medical product creators covering to address the current and potential future emergence of variants of...
HHS recently announced new actions to expand COVID-19 testing capacity across the US as part of President Joe Biden’s National Strategy for the COVID-19 Response and Pandemic Preparedness.
The...
AbbVie and Caribou Biosciences recently entered into a collaboration and license agreement to research and develop chimeric antigen receptor (CAR)-T cell therapeutics.
The companies will leverage...
Pfizer and the IDA Foundation recently partnered to provide equitable access to quality cancer treatments in nearly 70 developing countries.
Under the partnership agreement, millions of more patients...
Siemens Healthineers recently announced that it received the CE mark to use anterior nose swab sampling for its COVID-19 antigen test.
The CLINITEST Rapid COVID-19 Antigen Test is a point-of-care...
